Lung health is getting more attention than ever in this COVID time and consumers’ interest and knowledge of lung health are at their highest. This webinar deep dives into lung health concerns beyond seasonal colds and flu. It will discuss the harder issues of lung inflammation and pulmonary scarring (observed in COPD and patients recovered from COVID-19) as well as an innovative BerriQi® formulation.
Chaired by Nutraingredients Asia Editor-in-Chief, Gary Scattergood, we are anticipating a vigorous and lively discussion.
• Preclinical findings on BerriQi®
• BerriQi® reverses the irreversible scar tissue
• A sarcoidosis patent’s experience
• Upcoming clinical
• Formulating with BerriQi®